首页 > 最新文献

Revista colombiana de obstetricia y ginecologia最新文献

英文 中文
Traumatic brain injury in obstetric patients: challenges and management strategies [产科患者的脑损伤:挑战和管理策略]
Pub Date : 2025-08-15 DOI: 10.18597/rcog.4358
Javier Andrés Mora-Arteaga, Diego Camilo Reyes, Daniela Saa González, Isabella Rivera Tobar

Objective: To provide a conceptual framework for the management of traumatic brain injury (TBI) in pregnant women, integrating pathophysiological foundations, available scientific evidence, and current clinical strategies to support decision-making.

Materials and methods: Based on a hypothetical case that practically illustrates the topic, an explanatory document was developed using a structured narrative review. It describes the physiological changes of pregnancy relevant to TBI, the principles of initial resuscitation, the management of intracranial hypertension, the use of neuromonitoring, obstetric care, and the ethical implications associated with maternal death by neurologic criteria.

Results: Pregnancy involves anatomical and functional adaptations that alter the maternal response to trauma. These modifications affect the airway, hemodynamics, oxygenation, and cerebral autoregulation, necessitating adjustments in clinical management. Key aspects include initial stabilization, control of intracranial hypertension, neuromonitoring, obstetric care, and ethical considerations in scenarios of maternal death by neurologic criteria.

Conclusions: The management of TBI in pregnant patients is a clinical challenge that requires an understanding of maternal physiology and its impact on acute brain injury. Given the lack of specific guidelines and recommendations, those established for the general population should be applied with careful consideration of the physiological changes of pregnancy.

目的:提供一个概念框架,以处理孕妇的脑外伤(ECT),结合生理病理基础、现有科学证据和支持决策的现有临床战略。材料和方法:从一个假设的案例开始,以一种实际的方式说明主题,在结构化的叙述审查的基础上发展一个解释性的文件。它描述了与ECT相关的怀孕生理变化、初始复苏原则、颅内高血压的管理、神经监测的使用、产科方法以及与神经学标准有关的孕产妇死亡的伦理意义。结果:怀孕涉及解剖和功能适应,改变母亲对创伤的反应。这些变化影响气道、血流动力学、氧合和大脑的自我调节,这需要临床方法的调整。它强调了一些关键方面,如初始管理、颅内高血压的控制、神经监测、产科护理以及在基于神经学标准的孕产妇死亡情况下的伦理影响。结论:在孕妇中管理ECT是一项临床挑战,需要了解产妇生理学及其对急性脑损伤的影响。由于缺乏具体的指导方针和建议,一般人群的建议应考虑到怀孕期间的生理变化。
{"title":"Traumatic brain injury in obstetric patients: challenges and management strategies","authors":"Javier Andrés Mora-Arteaga, Diego Camilo Reyes, Daniela Saa González, Isabella Rivera Tobar","doi":"10.18597/rcog.4358","DOIUrl":"10.18597/rcog.4358","url":null,"abstract":"<p><strong>Objective: </strong>To provide a conceptual framework for the management of traumatic brain injury (TBI) in pregnant women, integrating pathophysiological foundations, available scientific evidence, and current clinical strategies to support decision-making.</p><p><strong>Materials and methods: </strong>Based on a hypothetical case that practically illustrates the topic, an explanatory document was developed using a structured narrative review. It describes the physiological changes of pregnancy relevant to TBI, the principles of initial resuscitation, the management of intracranial hypertension, the use of neuromonitoring, obstetric care, and the ethical implications associated with maternal death by neurologic criteria.</p><p><strong>Results: </strong>Pregnancy involves anatomical and functional adaptations that alter the maternal response to trauma. These modifications affect the airway, hemodynamics, oxygenation, and cerebral autoregulation, necessitating adjustments in clinical management. Key aspects include initial stabilization, control of intracranial hypertension, neuromonitoring, obstetric care, and ethical considerations in scenarios of maternal death by neurologic criteria.</p><p><strong>Conclusions: </strong>The management of TBI in pregnant patients is a clinical challenge that requires an understanding of maternal physiology and its impact on acute brain injury. Given the lack of specific guidelines and recommendations, those established for the general population should be applied with careful consideration of the physiological changes of pregnancy.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12384369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145777064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstetric hysterectomy as a key procedure for the obstetrician-gynecologist [产科子宫切除术作为妇产科医生的关键程序]。
Pub Date : 2025-07-30 DOI: 10.18597/rcog.4523
Cristhiam Sánchez, Hernando Gaitán Duarte

Editorial.

社论。
{"title":"Obstetric hysterectomy as a key procedure for the obstetrician-gynecologist","authors":"Cristhiam Sánchez, Hernando Gaitán Duarte","doi":"10.18597/rcog.4523","DOIUrl":"10.18597/rcog.4523","url":null,"abstract":"<p><p>Editorial.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and clinical outcomes of obstetric hysterectomies in patients treated at a tertiary hospital in Chile 智利一家三级医院产科子宫切除术患者的安全性和临床结果。
Pub Date : 2025-07-17 DOI: 10.18597/rcog.4349
Sebastián Lavanderos, Benjamín Moraga-Arias, Fernanda Muñoz-Baeza, Sebastián Cifuentes-Espinoza, Víctor Córdova-Padilla

Objective: To describe the incidence, clinical characteristics, and complications of obstetric hysterectomy in a tertiary hospital in Chile from 2021 to 2023.

Methods: Retrospective descriptive cohort study including all women with a gestational age ≥20 weeks or up to six weeks postpartum who underwent obstetric hysterectomy at Santiago Oriente Dr. Luis Tisné Brousse Hospital. Clinical and surgical data were collected from institutional records. Descriptive statistics were performed.

Results: Twenty-five obstetric hysterectomies were performed during the study period. Incidence per 1,000 live births decreased from 3.22 in 2021 to 1.81 in 2023. Postpartum hemorrhage was the main indication (52%), followed by placenta accreta spectrum (32%), infection (12%), and uterine rupture (4%). Supracervical hysterectomy was performed in 52% of cases, and total hysterectomy in 48%; 68% were emergencies. One intraoperative complication (bladder injury) was reported. Postoperative complications occurred in 84% of cases, the most frequent being anemia (84%) and hemorrhagic shock (36%). No significant associations were found between baseline characteristics and complications.

Conclusion: Although its incidence is declining, obstetric hysterectomy remains associated with high morbidity. Strengthening prevention, early detection, and timely multidisciplinary care is essential. Further prospective, multicenter studies are needed to inform strategies to improve maternal outcomes.

目的:描述2021年至2023年智利某三级医院产科子宫切除术的发生率、临床特点和并发症。方法:回顾性描述性队列研究,纳入所有孕周≥20周或产后6周在圣地亚哥东方医生路易斯·蒂斯内尔·布鲁斯医院行产科子宫切除术的妇女。临床和手术资料收集自机构记录。进行描述性统计。结果:研究期间共行25例产科子宫切除术。每千例活产的发病率从2021年的3.22降至2023年的1.81。产后出血为主要指征(52%),其次为胎盘增生症(32%)、感染(12%)、子宫破裂(4%)。宫颈上子宫切除术占52%,全子宫切除术占48%;68%是紧急情况。报告1例术中并发症(膀胱损伤)。84%的病例出现术后并发症,最常见的是贫血(84%)和失血性休克(36%)。基线特征与并发症之间未发现显著关联。结论:虽然产科子宫切除术的发病率正在下降,但其发病率仍然很高。加强预防、早期发现和及时的多学科护理至关重要。需要进一步的前瞻性、多中心研究来为改善孕产妇结局的策略提供信息。
{"title":"Safety and clinical outcomes of obstetric hysterectomies in patients treated at a tertiary hospital in Chile","authors":"Sebastián Lavanderos, Benjamín Moraga-Arias, Fernanda Muñoz-Baeza, Sebastián Cifuentes-Espinoza, Víctor Córdova-Padilla","doi":"10.18597/rcog.4349","DOIUrl":"10.18597/rcog.4349","url":null,"abstract":"<p><strong>Objective: </strong>To describe the incidence, clinical characteristics, and complications of obstetric hysterectomy in a tertiary hospital in Chile from 2021 to 2023.</p><p><strong>Methods: </strong>Retrospective descriptive cohort study including all women with a gestational age ≥20 weeks or up to six weeks postpartum who underwent obstetric hysterectomy at Santiago Oriente Dr. Luis Tisné Brousse Hospital. Clinical and surgical data were collected from institutional records. Descriptive statistics were performed.</p><p><strong>Results: </strong>Twenty-five obstetric hysterectomies were performed during the study period. Incidence per 1,000 live births decreased from 3.22 in 2021 to 1.81 in 2023. Postpartum hemorrhage was the main indication (52%), followed by placenta accreta spectrum (32%), infection (12%), and uterine rupture (4%). Supracervical hysterectomy was performed in 52% of cases, and total hysterectomy in 48%; 68% were emergencies. One intraoperative complication (bladder injury) was reported. Postoperative complications occurred in 84% of cases, the most frequent being anemia (84%) and hemorrhagic shock (36%). No significant associations were found between baseline characteristics and complications.</p><p><strong>Conclusion: </strong>Although its incidence is declining, obstetric hysterectomy remains associated with high morbidity. Strengthening prevention, early detection, and timely multidisciplinary care is essential. Further prospective, multicenter studies are needed to inform strategies to improve maternal outcomes.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12363514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of nervous system medications with fetal risk before and during pregnancy in an Argentine social security system [有胎儿风险的神经系统药物:在阿根廷社会保险中怀孕前和怀孕期间的使用]。
Pub Date : 2025-07-15 DOI: 10.18597/rcog.4347
Cecilia Anahi Alvarez Rotondo, Gustavo H Marín, Lupe Marín, Solange Mollo, Martín A Urtasun, Martín Cañás

Objective: To describe the dispensing of nervous system medications before and during pregnancy, according to the fetal risk category of the drug.

Material and methods: Descriptive drug utilization study of nervous system medications in a historical cohort (2020–2023) of pregnant women enrolled in a health insurance program in Argentina. Dispensed drugs were categorized into two groups: high fetal risk and non-high or unknown risk, based on the classification of selected regulatory agencies. The prevalence of use before and during pregnancy was measured, along with the cumulative incidence of drug discontinuation and initiation during pregnancy.

Results: Among the 6,369 pregnant women included, 4.7% received at least one drug from the evaluated group in the pre-pregnancy period, and 18.8% during pregnancy. This increase was mainly due to paracetamol, which rose from 1.5% to 13.4% during pregnancy. In contrast, the use of anxiolytics (1.6% to 0.7%), antidepressants (0.8% to 0.4%), and antiepileptics (0.7% to 0.4%) decreased. The prevalence of use of high-risk medications declined from 1.5% to 1% during pregnancy, with a cumulative discontinuation incidence of 81.3% and initiation incidence of 0.7%.

Conclusions: The dispensing of nervous system medications with high fetal risk was low in the studied cohort. Identifying the fetal risk associated with each drug is essential to optimize treatment selection for nervous system disorders in pregnant women. Prospective studies are needed to validate medication utilization patterns in the region and their associated fetal and neonatal outcomes.

目的:根据药物的胎儿风险类别,描述妊娠前和妊娠期间神经系统药物的使用情况。材料和方法:阿根廷一家健康保险公司的孕妇队列中神经系统药物使用的描述性研究(2020-2023年)。根据选定的监管机构的分类,分配的药物被分为高胎儿风险组和不高或未知组。我们测量了妊娠前和妊娠期间使用的流行率,以及妊娠期间停用和开始使用的累积发生率。结果:在6369名孕妇中,4.7%的人在前一阶段接受了评估组的任何药物,18.8%的人在怀孕期间接受了评估组的任何药物。增加的主要原因是怀孕期间服用扑热息痛,从1.5%上升到13.4%。相比之下,抗焦虑药(1.6%至0.7%)、抗抑郁药(0.8%至0.4%)和抗癫痫药(0.7%至0.4%)的使用有所下降。妊娠期间使用高危药物的患病率从1.5%下降到1%,累计停用率为81.3%,开始使用的患病率为0.7%。结论:在研究队列中,胎儿高危神经系统药物的配给率较低。重要的是要确定每种药物的胎儿风险,以优化孕妇神经系统疾病的治疗选择。需要进行前瞻性研究,以验证该区域的药物使用模式以及胎儿和新生儿的结果。
{"title":"Use of nervous system medications with fetal risk before and during pregnancy in an Argentine social security system","authors":"Cecilia Anahi Alvarez Rotondo, Gustavo H Marín, Lupe Marín, Solange Mollo, Martín A Urtasun, Martín Cañás","doi":"10.18597/rcog.4347","DOIUrl":"10.18597/rcog.4347","url":null,"abstract":"<p><strong>Objective: </strong>To describe the dispensing of nervous system medications before and during pregnancy, according to the fetal risk category of the drug.</p><p><strong>Material and methods: </strong>Descriptive drug utilization study of nervous system medications in a historical cohort (2020–2023) of pregnant women enrolled in a health insurance program in Argentina. Dispensed drugs were categorized into two groups: high fetal risk and non-high or unknown risk, based on the classification of selected regulatory agencies. The prevalence of use before and during pregnancy was measured, along with the cumulative incidence of drug discontinuation and initiation during pregnancy.</p><p><strong>Results: </strong>Among the 6,369 pregnant women included, 4.7% received at least one drug from the evaluated group in the pre-pregnancy period, and 18.8% during pregnancy. This increase was mainly due to paracetamol, which rose from 1.5% to 13.4% during pregnancy. In contrast, the use of anxiolytics (1.6% to 0.7%), antidepressants (0.8% to 0.4%), and antiepileptics (0.7% to 0.4%) decreased. The prevalence of use of high-risk medications declined from 1.5% to 1% during pregnancy, with a cumulative discontinuation incidence of 81.3% and initiation incidence of 0.7%.</p><p><strong>Conclusions: </strong>The dispensing of nervous system medications with high fetal risk was low in the studied cohort. Identifying the fetal risk associated with each drug is essential to optimize treatment selection for nervous system disorders in pregnant women. Prospective studies are needed to validate medication utilization patterns in the region and their associated fetal and neonatal outcomes.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert consensus on vaccination as a primary prevention strategy for women of reproductive age, pregnant, or adulthood [关于将疫苗接种作为育龄、怀孕或成年妇女的主要预防战略的专家共识]。
Pub Date : 2025-06-20 DOI: 10.18597/rcog.4310
Jezid Miranda Quintero, Marcela Celis-Amórtegui, María Cecilia Arturo Rojas, Laura Mendoza Rosado, Carlos Fernando Grillo-Ardila, Elvia Karina Grillo-Ardila, Juan José Ramírez-Mosquera, Luis Alexander Lovera, María José Ramírez-Mosquera
<p><strong>Objective: </strong>To generate recommendations for vaccinating women at different stages of their lives, in order to reduce potential variability in current use in Colombia.</p><p><strong>Materials and methods: </strong>The guideline development group consisted of professionals from the health sector. All participants submitted written conflict-of interest declarations. Answerable clinical questions were formulated, outcomes were graded, and a literature search was conducted in Medline/PubMed, Embase, and LILACS. The search also included grey literature sources and was updated on May 14, 2024, with no restrictions on date or language. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology was used to determine the quality of evidence and the strength of recommendations. Due to the limitations of the retrieved studies—particularly concerning the applicability of the evidence—expert opinion was sought. Formal consensus was achieved following the RAND/UCLA methodology (RAND Corporation/University of California, Los Angeles). Prior to publication, the document underwent peer review.</p><p><strong>Results: </strong>The following recommendations were developed:1. The development group suggests that women who are not immune to mumps, measles, or rubella (e.g., IgG negative) should be vaccinated during the preconception period. Quality of evidence: low ⨁⨁◯◯2. The development group suggests that all women in the preconception period be vaccinated against varicella if they lack confirmed natural immunity (e.g., negative varicella-zoster virus IgG antibodies). Quality of evidence: very low ⨁◯◯◯3. The development group suggests that women living in yellow fever endemic areas be vaccinated during the preconception period if they have not been previously immunized. Quality of evidence: very low ⨁◯◯◯4. The development group suggests that adolescent girls and young adult women receive the human papillomavirus (HPV) vaccine , 3 doses (0.2 and 6 months) to reduce cervical cancer incidence and mortality. Quality of evidence: moderate ⨁⨁⨁◯5. The development group suggests that pregnant women be immunized against tetanus, diphtheria, and pertussis during pregnancy to reduce infection risk in both the mother and newborn. Quality of evidence: low ⨁⨁◯◯6. The development group suggests inf luenza vaccination at any stage of pregnancy to reduce infection risk in the mother and in infants up to six months of age. Quality of evidence: very low ⨁◯◯◯7. The development group suggests maternal COVID-19 vaccination at any stage of pregnancy to reduce the risk of hospitalization and death of the mother and the newborn during the first four months of life. Quality of evidence: very low ⨁◯◯◯8. The development group suggests vaccination against respiratory syncytial virus (RSV) during pregnancy to reduce hospitalization risk in the newborn. Quality of evidence: very low ⨁◯◯◯9. The development group suggests that older adult wom
目标:为妇女在生命的不同阶段接种疫苗提出建议,以减少哥伦比亚目前使用疫苗的可能性。材料和方法:开发团队由来自卫生领域的专业人员组成。所有参与者都以书面形式声明了他们的利益冲突。在Medline/PubMed、Embase和Lilacs上提出了有争议的临床问题,对结果进行了分类,并检索了信息。该搜索还包括灰色文献的来源,并于2024年5月14日更新,不受日期或语言的限制。采用了GRADE(推荐程度评估、发展和评价)方法,以确定证据的质量和建议的力度。由于恢复的研究的局限性,特别是在涉及证据适用性的局限性时,征求了专家的意见。根据兰德公司/加州大学洛杉矶分校(RAND Corporation/ UCLA)的方法达成了正式共识。在发表之前,该论文经过了同行评审。结果:制定了以下建议:•开发小组建议对腮腺炎、麻疹或风疹(如IgG阴性)没有免疫力的妇女在怀孕前接种疫苗。证据质量:低⨁⨁◯◯•开发小组建议,如果没有确认的自然免疫力(例如,带状水痘病毒IgG抗体阴性),所有产前妇女都应该接种水痘疫苗。证据质量:很低的⨁◯◯◯•开发小组建议生活在黄热病流行地区的妇女,如果以前没有接种过疫苗,可以在怀孕前接种疫苗。证据质量:很低⨁◯◯◯•开发小组建议青少年和年轻成年人接种人乳头瘤病毒(HPV)疫苗,3剂(0.2和6个月),以降低宫颈癌的发病率和死亡率。•开发小组建议孕妇在怀孕期间接种破伤风、白喉和百日咳疫苗,以降低母亲和新生儿感染的风险。证据质量:低⨁⨁◯◯•开发小组建议在任何怀孕年龄接种流感疫苗,目的是将母亲和新生儿感染流感的风险降低到6个月以下。证据质量:极低的⨁◯◯◯•开发小组建议在任何怀孕年龄接种COVID-19孕产妇疫苗,以降低母亲和新生儿在出生后的前四个月住院和死亡的风险。证据质量:很低⨁◯◯◯•开发小组建议孕妇接种呼吸道合胞病毒(VSR)疫苗,以降低新生儿住院的风险。证据质量:极低的⨁◯◯◯•开发小组建议老年妇女接种带状疱疹疫苗,以减少与带状疱疹相关的发病率。证据质量:中等⨁⨁⨁◯•开发小组建议老年妇女接种流感疫苗,以减少急性呼吸道感染(IRA)的发病率。证据质量:中等⨁⨁⨁◯•开发小组建议老年妇女接种肺炎球菌疫苗,以减少肺炎和侵袭性肺炎球菌疾病的发病率。证据质量:低⨁⨁◯◯•开发小组建议老年妇女接种VSR疫苗,以减少急性呼吸道感染和下呼吸道感染的发病率。证据质量:baja⨁⨁◯◯•开发小组建议,生活在黄热病流行地区的老年妇女如果以前没有接种过疫苗,就应该接种疫苗。证据质量:很低⨁◯◯◯结论:建议将接种疫苗作为妇女生命不同阶段的初级预防策略。考虑到证据的质量和一些研究的适用性的严重局限性,特别是在孕妇中,需要更多的研究来评估这种干预在生命的这个阶段的安全性和有效性。
{"title":"Expert consensus on vaccination as a primary prevention strategy for women of reproductive age, pregnant, or adulthood","authors":"Jezid Miranda Quintero, Marcela Celis-Amórtegui, María Cecilia Arturo Rojas, Laura Mendoza Rosado, Carlos Fernando Grillo-Ardila, Elvia Karina Grillo-Ardila, Juan José Ramírez-Mosquera, Luis Alexander Lovera, María José Ramírez-Mosquera","doi":"10.18597/rcog.4310","DOIUrl":"10.18597/rcog.4310","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To generate recommendations for vaccinating women at different stages of their lives, in order to reduce potential variability in current use in Colombia.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;The guideline development group consisted of professionals from the health sector. All participants submitted written conflict-of interest declarations. Answerable clinical questions were formulated, outcomes were graded, and a literature search was conducted in Medline/PubMed, Embase, and LILACS. The search also included grey literature sources and was updated on May 14, 2024, with no restrictions on date or language. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology was used to determine the quality of evidence and the strength of recommendations. Due to the limitations of the retrieved studies—particularly concerning the applicability of the evidence—expert opinion was sought. Formal consensus was achieved following the RAND/UCLA methodology (RAND Corporation/University of California, Los Angeles). Prior to publication, the document underwent peer review.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The following recommendations were developed:\u00001. The development group suggests that women who are not immune to mumps, measles, or rubella (e.g., IgG negative) should be vaccinated during the preconception period. Quality of evidence: low ⨁⨁◯◯\u00002. The development group suggests that all women in the preconception period be vaccinated against varicella if they lack confirmed natural immunity (e.g., negative varicella-zoster virus IgG antibodies). Quality of evidence: very low ⨁◯◯◯\u00003. The development group suggests that women living in yellow fever endemic areas be vaccinated during the preconception period if they have not been previously immunized. Quality of evidence: very low ⨁◯◯◯\u00004. The development group suggests that adolescent girls and young adult women receive the human papillomavirus (HPV) vaccine , 3 doses (0.2 and 6 months) to reduce cervical cancer incidence and mortality. Quality of evidence: moderate ⨁⨁⨁◯\u00005. The development group suggests that pregnant women be immunized against tetanus, diphtheria, and pertussis during pregnancy to reduce infection risk in both the mother and newborn. Quality of evidence: low ⨁⨁◯◯\u00006. The development group suggests inf luenza vaccination at any stage of pregnancy to reduce infection risk in the mother and in infants up to six months of age. Quality of evidence: very low ⨁◯◯◯\u00007. The development group suggests maternal COVID-19 vaccination at any stage of pregnancy to reduce the risk of hospitalization and death of the mother and the newborn during the first four months of life. Quality of evidence: very low ⨁◯◯◯\u00008. The development group suggests vaccination against respiratory syncytial virus (RSV) during pregnancy to reduce hospitalization risk in the newborn. Quality of evidence: very low ⨁◯◯◯\u00009. The development group suggests that older adult wom","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respectful maternity care during childbirth: postnatal women's perspectives. Cross-sectional study from central India: February - December 2023. 分娩期间尊重产妇护理:产后妇女的观点。印度中部横断面研究:2023年2月至12月。
Pub Date : 2025-06-20 DOI: 10.18597/rcog.4433
Naseema Shafqat, K Jyotika, K Pushpalatha, Radha K, Malini Mondal

Objective: This study assesses postnatal women's perceptions of Respectful Maternity Care (RMC), aiming to identify key areas for improvement.

Methods: A cross-sectional quantitative study was carried out in selected urban areas of Bhopal, India. Women aged 18 years and above, who had given birth to a healthy newborn within the previous 42 days, were eligible to participate if they resided in the study area, could understand Hindi or English, and had no cognitive impairments. Estimated sample size was 238 with 77% estimated prevalence, 5% margin of error, and 95% confidence level; 270 women were recruited using purposive sampling from 18 urban wards and 98 Anganwadi centres. Participants were approached directly and interviewed in person using a structured questionnaire and the validated RMC Scale by Sheferaw et al. The primary outcome was the level of perceived respectful maternity care, while independent variables included socio-demographic and obstetric factors such as age, education, place of delivery, and number of antenatal visits. Data were analysed using descriptive statistics and Fisher's exact test due to the non-normal distribution of variables.

Results: Of the 270 participants, 51.2% were aged 25-30 years and 75.3% were Hindus. Most deliveries (57.4%) were normal vaginal deliveries, and 75.6% occurred in government hospitals. Overall, 82.6% of women reported experiencing RMC. Domain-wise, 91% experienced Friendly Care, 93.3% Abuse-Free Care, 79.7% Timely Care, and 87.7% Discrimination-Free Care. Item-wise analysis revealed strengths in provider kindness and clear communication, though about 15-25% of women experienced delays, verbal mistreatment, or felt disrespected. Socioeconomic status had a significant influence in all four domains (p < 0.05), with women from higher income groups reporting more positive experiences. Higher education level was also associated with greater awareness and recognition of discriminatory practices (p = 0.014), Obstetric variables such as mode of delivery (p = 0.031), time of delivery (p = 0.003), antenatal visits (p = 0.017, 0.029), and high-risk pregnancy (p = 0.037) showed domain-specific associations.

Conclusion: Although most women described their childbirth experience as respectful, notable gaps remain in timely and equitable care. Addressing delays and reducing discrimination, particularly in public healthcare settings, are essential to ensuring that all women receive dignified, person-centred maternity care, regardless of their background.

目的:本研究评估了产后妇女对尊重产妇护理(RMC)的看法,旨在确定改进的关键领域。方法:在印度博帕尔选定的城市地区进行横断面定量研究。在过去42天内生下健康新生儿的18岁及以上妇女,如果她们居住在研究地区,能听懂印地语或英语,并且没有认知障碍,就有资格参加研究。估计样本量为238例,估计患病率为77%,误差幅度为5%,置信水平为95%;通过有目的抽样从18个城市病房和98个安干瓦迪中心招募了270名妇女。参与者直接接触并亲自访问,使用结构化问卷和经验证的RMC量表(由Sheferaw等人设计)。主要结果是感知到的尊重产妇护理水平,而独立变量包括社会人口统计学和产科因素,如年龄、教育程度、分娩地点和产前检查次数。由于变量的非正态分布,采用描述性统计和Fisher精确检验对数据进行分析。结果:在270名参与者中,51.2%的人年龄在25-30岁之间,75.3%是印度教徒。大多数分娩(57.4%)是正常阴道分娩,75.6%是在公立医院分娩。总体而言,82.6%的女性报告经历过RMC。在领域方面,91%的人经历过友好护理,93.3%的人经历过无虐待护理,79.7%的人经历过及时护理,87.7%的人经历过无歧视护理。项目分析显示,尽管约有15-25%的女性经历过延误、言语虐待或感觉不受尊重,但在服务提供者的善良和清晰沟通方面仍有优势。社会经济地位对所有四个领域都有显著影响(p < 0.05),高收入群体的女性报告的积极体验更多。高等教育水平也与对歧视行为的更多认识和认识相关(p = 0.014),分娩方式(p = 0.031)、分娩时间(p = 0.003)、产前检查(p = 0.017、0.029)和高危妊娠(p = 0.037)等产科变量显示出特定领域的关联。结论:尽管大多数妇女描述她们的分娩经历是尊重的,但在及时和公平的护理方面仍然存在显着差距。解决延误和减少歧视问题,特别是在公共卫生保健环境中,对于确保所有妇女无论其背景如何都能获得有尊严的、以人为本的产科护理至关重要。
{"title":"Respectful maternity care during childbirth: postnatal women's perspectives. Cross-sectional study from central India: February - December 2023.","authors":"Naseema Shafqat, K Jyotika, K Pushpalatha, Radha K, Malini Mondal","doi":"10.18597/rcog.4433","DOIUrl":"10.18597/rcog.4433","url":null,"abstract":"<p><strong>Objective: </strong>This study assesses postnatal women's perceptions of Respectful Maternity Care (RMC), aiming to identify key areas for improvement.</p><p><strong>Methods: </strong>A cross-sectional quantitative study was carried out in selected urban areas of Bhopal, India. Women aged 18 years and above, who had given birth to a healthy newborn within the previous 42 days, were eligible to participate if they resided in the study area, could understand Hindi or English, and had no cognitive impairments. Estimated sample size was 238 with 77% estimated prevalence, 5% margin of error, and 95% confidence level; 270 women were recruited using purposive sampling from 18 urban wards and 98 Anganwadi centres. Participants were approached directly and interviewed in person using a structured questionnaire and the validated RMC Scale by Sheferaw et al. The primary outcome was the level of perceived respectful maternity care, while independent variables included socio-demographic and obstetric factors such as age, education, place of delivery, and number of antenatal visits. Data were analysed using descriptive statistics and Fisher's exact test due to the non-normal distribution of variables.</p><p><strong>Results: </strong>Of the 270 participants, 51.2% were aged 25-30 years and 75.3% were Hindus. Most deliveries (57.4%) were normal vaginal deliveries, and 75.6% occurred in government hospitals. Overall, 82.6% of women reported experiencing RMC. Domain-wise, 91% experienced Friendly Care, 93.3% Abuse-Free Care, 79.7% Timely Care, and 87.7% Discrimination-Free Care. Item-wise analysis revealed strengths in provider kindness and clear communication, though about 15-25% of women experienced delays, verbal mistreatment, or felt disrespected. Socioeconomic status had a significant influence in all four domains (p < 0.05), with women from higher income groups reporting more positive experiences. Higher education level was also associated with greater awareness and recognition of discriminatory practices (p = 0.014), Obstetric variables such as mode of delivery (p = 0.031), time of delivery (p = 0.003), antenatal visits (p = 0.017, 0.029), and high-risk pregnancy (p = 0.037) showed domain-specific associations.</p><p><strong>Conclusion: </strong>Although most women described their childbirth experience as respectful, notable gaps remain in timely and equitable care. Addressing delays and reducing discrimination, particularly in public healthcare settings, are essential to ensuring that all women receive dignified, person-centred maternity care, regardless of their background.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delays in the diagnosis and treatment of cervical cancer in the department of Meta, 2017–2023: a cross-sectional study [2017-2023年梅塔省宫颈癌诊断和治疗延误。”横切研究。
Pub Date : 2025-05-26 DOI: 10.18597/rcog.4277
César García-Balaguera, Sandra Patricia Ruiz Rodríguez

Objective: To describe the prevalence of the different delays in the diagnosis and treatment of cervical cancer, to estimate its incidence in the Department of Meta (Colombia) in recent years, and to conduct an exploratory analysis of potential factors associated with these delays

Material and methods: Cross-sectional study of newly reported cases of cervical cancer in the Epidemiological Surveillance System of the National Institute of Health of Colombia between 2017 and 2023. The proportion of cases in which delays in the care process were identified was described, as well as the annual incidence rate of cervical cancer based on population data.

Results: A total of 824 cases were included. Delays of more than 60 days in the care process were observed in 56.9% of the cases. These delays were attributed to patients in 33.9% of cases due to lack of knowledge or geographic, cultural, or economic barriers; to health services in 36.2% of cases due to lack of timely care; and to insurers in 22.9% of cases due to administrative barriers.

Conclusions: Delays in the care process are common in Meta. These delays particularly affect women over 40 years of age and those residing in rural areas. Analytic and qualitative studies are needed to further explore the underlying causes of these delays.

目的:描述宫颈癌诊断和治疗延误的不同流行情况,对近年来梅塔省(哥伦比亚)的发病率进行估计,并对与延误有关的可能因素进行探索性分析。材料和方法:对哥伦比亚国家卫生研究所流行病学监测系统2017 - 2023年期间新报告的宫颈癌病例进行横断面研究。它描述了在治疗过程中发现延误的病例比例,并根据人口数据描述了每年宫颈癌的发病率。结果:共纳入824例。56.9%的病例在治疗过程中出现了60天以上的延误。这些延误的原因是:33.9%的患者缺乏知识或地理、文化或经济障碍,36.2%的患者缺乏获得保健的机会,22.9%的患者缺乏行政障碍。结论:Meta治疗过程中经常出现延误。这些延误尤其影响到40岁以上和生活在农村地区的妇女。需要进行分析和定性研究,更深入地探讨延误的原因。
{"title":"Delays in the diagnosis and treatment of cervical cancer in the department of Meta, 2017–2023: a cross-sectional study","authors":"César García-Balaguera, Sandra Patricia Ruiz Rodríguez","doi":"10.18597/rcog.4277","DOIUrl":"10.18597/rcog.4277","url":null,"abstract":"<p><strong>Objective: </strong>To describe the prevalence of the different delays in the diagnosis and treatment of cervical cancer, to estimate its incidence in the Department of Meta (Colombia) in recent years, and to conduct an exploratory analysis of potential factors associated with these delays</p><p><strong>Material and methods: </strong>Cross-sectional study of newly reported cases of cervical cancer in the Epidemiological Surveillance System of the National Institute of Health of Colombia between 2017 and 2023. The proportion of cases in which delays in the care process were identified was described, as well as the annual incidence rate of cervical cancer based on population data.</p><p><strong>Results: </strong>A total of 824 cases were included. Delays of more than 60 days in the care process were observed in 56.9% of the cases. These delays were attributed to patients in 33.9% of cases due to lack of knowledge or geographic, cultural, or economic barriers; to health services in 36.2% of cases due to lack of timely care; and to insurers in 22.9% of cases due to administrative barriers.</p><p><strong>Conclusions: </strong>Delays in the care process are common in Meta. These delays particularly affect women over 40 years of age and those residing in rural areas. Analytic and qualitative studies are needed to further explore the underlying causes of these delays.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ‘how’ and ‘why’ of qualitative research in health [卫生定性研究的“如何”和“为什么”]。
Pub Date : 2025-04-11 DOI: 10.18597/rcog.4450
Ximena Briceño-Morales, Clara Briceño-Morales

Editorial.

社论。
{"title":"The ‘how’ and ‘why’ of qualitative research in health","authors":"Ximena Briceño-Morales, Clara Briceño-Morales","doi":"10.18597/rcog.4450","DOIUrl":"10.18597/rcog.4450","url":null,"abstract":"<p><p>Editorial.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor about “Meaning of having to cope with voluntary termination of late pregnancy in women undergoing the procedure in healthcare institutions of two Colombian cities” [给编辑的信,关于“在哥伦比亚两个城市的保健机构接受手术的妇女必须面对自愿终止妊娠的问题”]。
Pub Date : 2025-04-11 DOI: 10.18597/rcog.4385
Karen Nohely Torrejón Ordóñez

Letter to the Editor

Carta编辑。
{"title":"Letter to the Editor about “Meaning of having to cope with voluntary termination of late pregnancy in women undergoing the procedure in healthcare institutions of two Colombian cities”","authors":"Karen Nohely Torrejón Ordóñez","doi":"10.18597/rcog.4385","DOIUrl":"10.18597/rcog.4385","url":null,"abstract":"<p><p>Letter to the Editor</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gigantomastia following the use of a subdermal contraceptive: a case report [皮下避孕后的巨口术:一个病例报告]。
Pub Date : 2025-04-11 DOI: 10.18597/rcog.4258
Álvaro Andrés Montenegro, Ligia María Tamayo Escobar, Laura María Sanmiguel Ávila, Paola Andrea Kafury Goeta, Federico Reina Ramírez, Juan Santiago Serna

Objective: To describe a case of secondary gigantomastia following the use of a subdermal contraceptive implant, as well as to evaluate the probable causality of the implant as the cause of this condition.

Materials and methods: We present the case of a 23-year-old nulligravid patient who, one month after the insertion of a subdermal contraceptive implant, began to experience rapid breast enlargement, mastalgia, localized pruritus, back pain, and an anxiety disorder. Complementary studies ruled out a hormonal, oncological, or pregnancy-related etiology. Two months after the insertion of the subdermal implant, it was removed; however, breast gland enlargement continued after its removal. Reduction mammoplasty was required for definitive treatment. The Naranjo algorithm was applied to determine the likelihood of a causal relationship.

Conclusions: To the best of the authors' knowledge, the probable association between gigantomastia and the use of subdermal contraceptives has not been previously described in the literature. It is important to monitor patients with progesterone implants for the development of gigantomastia.

目的:描述使用皮下避孕药具后继发性巨乳症的病例,并评估植入物作为该疾病原因的可能随机性。材料和方法:本研究以一名23岁的无孕患者为例,她在插入皮下避孕药具一个月后出现乳房加速生长、乳腺疼痛、局部瘙痒、背痛和焦虑障碍。补充研究排除了激素、肿瘤学或与怀孕有关的病因。在插入皮下避孕药具两个月后,该避孕药具被撤回;然而,在她退休后,乳腺继续生长。最后的治疗需要缩小乳房成形术。纳兰霍算法被用来确定因果关系的概率。结论:据作者所知,巨口术与皮下避孕药具使用之间的可能关系尚未在文献中描述。对植入黄体酮的患者进行巨口手术的监测是很重要的。
{"title":"Gigantomastia following the use of a subdermal contraceptive: a case report","authors":"Álvaro Andrés Montenegro, Ligia María Tamayo Escobar, Laura María Sanmiguel Ávila, Paola Andrea Kafury Goeta, Federico Reina Ramírez, Juan Santiago Serna","doi":"10.18597/rcog.4258","DOIUrl":"10.18597/rcog.4258","url":null,"abstract":"<p><strong>Objective: </strong>To describe a case of secondary gigantomastia following the use of a subdermal contraceptive implant, as well as to evaluate the probable causality of the implant as the cause of this condition.</p><p><strong>Materials and methods: </strong>We present the case of a 23-year-old nulligravid patient who, one month after the insertion of a subdermal contraceptive implant, began to experience rapid breast enlargement, mastalgia, localized pruritus, back pain, and an anxiety disorder. Complementary studies ruled out a hormonal, oncological, or pregnancy-related etiology. Two months after the insertion of the subdermal implant, it was removed; however, breast gland enlargement continued after its removal. Reduction mammoplasty was required for definitive treatment. The Naranjo algorithm was applied to determine the likelihood of a causal relationship.</p><p><strong>Conclusions: </strong>To the best of the authors' knowledge, the probable association between gigantomastia and the use of subdermal contraceptives has not been previously described in the literature. It is important to monitor patients with progesterone implants for the development of gigantomastia.</p>","PeriodicalId":101422,"journal":{"name":"Revista colombiana de obstetricia y ginecologia","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista colombiana de obstetricia y ginecologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1